Autoimmunity and kidney diseases
41 – 50 of 140
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Severe infections in patients with ANCA-associated vasculitis treated with rituximab
(
- Contribution to journal › Article
-
Mark
Evaluation of revised classification criteria for giant cell arteritis and its clinical phenotypes
(
- Contribution to journal › Article
-
Mark
Spike-Dependent Opsonization Indicates Both Dose-Dependent Inhibition of Phagocytosis and That Non-Neutralizing Antibodies Can Confer Protection to SARS-CoV-2
(
- Contribution to journal › Article
-
Mark
The Sound of Interconnectivity; The European Vasculitis Society 2022 Report
(
- Contribution to journal › Article
-
Mark
Methotrexate Treatment Suppresses Monocytes in Nonresponders to Pneumococcal Conjugate Vaccine in Rheumatoid Arthritis Patients
(
- Contribution to journal › Article
- 2021
-
Mark
Comment on: EPIDEMIOLOGY OF BIOPSY-CONFIRMED GIANT CELL ARTERITIS IN SOUTHERN SWEDEN-AN UPDATE ON INCIDENCE AND FIRST PREVALENCE ESTIMATE: Reply
(
- Contribution to journal › Article
-
Mark
Trajectory of Healthcare Resources Utilization in Giant Cell Arteritis – A Population-Based Study
(
- Contribution to journal › Article
-
Mark
Incidence and predictors of severe infections in ANCA-associated vasculitis: a population-based cohort study.
(
- Contribution to journal › Article
-
Mark
Bone Marrow Neutrophils of Multiple Myeloma Patients Exhibit Myeloid-Derived Suppressor Cell Activity
(
- Contribution to journal › Article
-
Mark
Association of venous thromboembolic events with skin, pulmonary and kidney involvement in ANCA-associated vasculitis : A multinational study
(
- Contribution to journal › Article